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A B S T R A C T
Prevention of fragility fractures in older people has become a public health priority, although the most
appropriate and cost-effective strategy remains unclear. In the present statement, the Interest group on
falls and fracture prevention of the European union geriatric medicine society (EUGMS), in collaboration
with the International association of gerontology and geriatrics for the European region (IAGG-ER), the
European union of medical specialists (EUMS), the Fragility fracture network (FFN), the International
osteoporosis foundation (IOF) – European society for clinical and economic aspects of osteoporosis and
osteoarthritis (ECCEO), outlines its views on the main points in the current debate in relation to the
primary and secondary prevention of falls, the diagnosis and treatment of bone fragility, and the place of
combined falls and fracture liaison services for fracture prevention in older people.
 2016 Published by Elsevier Masson SAS.1. Introduction
Three quarters of all vertebral and non-vertebral fractures occur
among adults aged 65 years or older and over three quarters of hip
fractures occur in people aged 75 or over [1]. The major inﬂuence of
ageing on fracture risk is mainly due to the strong impact of age
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associated with excess morbidity and mortality, increased hip
fracture risk, decreased quality of life, and high health care costs
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prevent major fractures in older people however remains a hotly
debated topic [11–14]. In the present statement, the Interest group
on falls and fracture prevention of the European union geriatric
medicine society (EUGMS), in collaboration with the International
association of gerontology and geriatrics for the European region
(IAGG-ER), the European union of medical specialists (EUMS), the
International osteoporosis foundation – European society for
clinical and economic aspects of osteoporosis and osteoarthritis,
outlines its views on the main points in the current debate.
2. Primary and secondary prevention related to falls
In adults, falls occur predominantly in older people. In
populations over age 65, a third of community-dwelling people
fall at least once per year and in those aged 80 years or more a half
fall over the course of a year [15,16]. More than 80% of non-
vertebral fractures result from a fall [2,3]. Around 10% of falls result
in a fracture [17,18] and 2% in a hip fracture [19]. The efﬁcacy of
falls prevention interventions to reduce fractures is debated
[13,14], in part because it depends on the fall risk proﬁle of people
and the type of intervention program [20,21].
There is no international consensus for assessing the fall risk
proﬁle of older people, even if it is well-understood that people at
higher risk of future falls are those aged 75 or older, those who have
fallen during the previous 12 months or those who have fear of
falling or signiﬁcant gait, muscle strength, or balance problems
[16,22–28]. The fall risk proﬁle is also dependent on the setting and
some other factors, including cognitive impairment which may be
associated with increased risk-taking. Even though balance, gait, and
muscle function decline increase the risk of falling, the relationship
is not completely linear since those with most problems (i.e. bed-
ridden) usually have a lower falls risk, similar to those without such
problems, presumably due to low exposure to risk [29].
Notwithstanding the lack of consensus in assessing fall risk
proﬁle, there is rather consistent evidence in subjects with low to
moderate falls risk, usually community dwelling, that multicom-
ponent exercise programs, including progressive, challenging and
regular exercises designed to improve balance, muscle strength,
and protective responses in case of destabilisation, are effective in
the reduction of serious falls and non-vertebral fractures
[21,24,30,31]. The studies are however insufﬁciently powered
to demonstrate a signiﬁcant effect on hip fracture risk
[21,24,30]. Single interventions including treatment of some
vision problems or carotid sinus hypersensitivity, vitamin D
supplementation in deﬁcient patients, gradual withdrawal of
psychotropic medication, or improving the safety of indoor
activities and outdoor walking environments are also effective for
suitable patient groups in the prevention of falls, but the effect on
fracture risk is not clear [21,32,33]. Multifactorial interventions, a
combination of interventions linked to the individual’s risk
proﬁle, seem no more effective in preventing falls than single
targeted interventions (e.g. community exercise or fall prevention
programs) [21,34].
In people at high risk of falls single targeted interventions seem
less effective, e.g. in older nursing home residents, the only single
intervention that has reduced falls is vitamin D supplementation
[20]. Other interventions have been ineffective or inconsistent for
falls although the rate of recurrent falls may be reduced [35]. A
multifactorial and interprofessional approach, determined by
individual assessment of functional, medical, and social concerns,
may be a more appropriate strategy to prevent falls in older people
at high risk of falling [20,22–34,36]. Moreover, this tailored
approach [37] may provide opportunities to address previously
unidentiﬁed health problems (e.g. impaired cognition, diabetes,
Parkinson’s disease, osteoporosis) [9,38], conferring beneﬁtsbeyond falls prevention [39,40]. People at high risk of fall are
most often frail patients [40] and multifactorial approach in this
population has been shown to improve the ability to live safely and
independently [41].
Taken together, the EUGMS supports:
 the set-up of a working group that would develop consensus
international operational deﬁnitions and diagnostic criteria for
assessing the risk of falling to be used in clinical practice as well
as in research studies;
 the 2010 American geriatrics society/British geriatrics society
joint guideline urging practitioners to screen, at least annually,
older patients for risk of falling [42];
 that above evidenced-based measures, especially evidence-
based community exercise fall prevention programs, should be
widely available to prevent non-vertebral fractures in older
people at low or moderate risk of falling [9];
 that people at high risk should be able to access individually
tailored multifactorial measures based on a comprehensive
geriatric assessment.
EUGMS recommends continued and expanded provision of
evidence based fall prevention programmes such as those being
promoted by ProFouND (www.profound.eu.org).
3. Primary and secondary prevention related to bone health
It is widely recognized that lifestyle measures (regular weight-
bearing exercises, balanced diet, including calcium intake,
avoiding smoking and excessive alcohol consumption) and
measures aimed at reducing adverse effects on bone of drugs
and diseases, including renal diseases, have to be recommended
throughout life in everyone. They are beneﬁcial in optimizing
skeletal development [43–46] and limiting bone loss during
adulthood [47].
Whereas there are well-established deﬁnitions of osteoporosis
[13,14], there is much current debate on what is the target
population that may potentially beneﬁt from treatments acting on
bone metabolism (TABM) [13,14,48–51].
Osteoporosis is currently deﬁned by bone densitometry
(densitometry osteoporosis) when the bone mineral density
(BMD) is 2.5 SD or more below that of the mean level for a
young-adult reference population (T-score  2.5 at the lumbar
spine or the hip, or at the distal radius when the hip and lumbar
spine cannot be measured or are unusable or uninterpretable) [52–
54]. Aortic calciﬁcation and osteoarthrosis that increase progres-
sively with age may be a source of accuracy error in the
measurement of lumbar spine BMD in older people [55,56]. How-
ever, for a given BMD, the risk of major fractures depends on other
risk factors for bone fragility, of which age is the most important
one, which are taken into account in different fracture prediction
tools such as the most used FRAX1 tool (www.shef.ac.uk.FRAX) or
the Garvan fracture risk calculator (www.garvan.org.au/
bone-fracture) or the Q-fracture risk calculator (www.qfracture.
org). Fragility fracture risk should therefore take into account not
only BMD but also other risk factors of bone fragility, by using
fracture prediction tools, and falls risk [57]. Since falls and
osteoporosis are independent risk factors of non-vertebral
fractures, osteoporosis should be ascertained not only in patients
with conditions known to induce bone fragility but also in patients
at risk of falls and vice versa [58]. The prevalence of osteoporosis
detected by DXA BMD measurement is high in fallers with
sarcopenia, impaired mobility, and weight loss, which are risk
factors for both falls and osteoporosis [58].
A fracture is considered a fragility or low energy fracture when it
is the result of a minimal trauma, such as a fall from a standing height
H. Blain et al. / European Geriatric Medicine 7 (2016) 519–525 523or less. However, a fall from standing height without any protective
response generates an amount of energy which is at least 10 times
the energy required to fracture the proximal femur of an elderly
woman [59]. Diagnosis of fragility fracture should therefore be set
after a careful comprehensive assessment including:
 fracture mechanism consideration (energy of the trauma);
 bone strength estimate, based on bone mineral density (BMD),
considering that densitometry osteoporosis is observed in
around 60% and 40% hip fractured women and men, respectively
[60], fracture type (comminuted or not, for example) and
operator’s subjective assessment of bone quality in the case of
surgery.
The cost-effectiveness of the pharmacological approach of
treating osteoporosis (and therefore on searching for osteoporosis
by Dual-energy X-ray absorptiometry [DXA]) is also debated
[13]. However, several licensed TABM have shown their ability to
prevent major fractures in people (most often women) with a
T-score  2.5 at the spine or the hip (raloxifene has only been
shown effective in preventing vertebral fractures) [14,61] or after a
hip fracture [61]. Relative risk reductions of spine and non-
vertebral fractures by TABM in subjects with bone densitometry
diagnosed osteoporosis are 40–60% and 20–40%, respectively
[14,61]. Number-needed-to-treat (NNT) to prevent a fracture is
lower in people at high risk of fractures, and especially in those
with prior fragility fractures [13,37,61–73].
Taken together, EUGMS supports recommendations that:
 osteoporosis should be ascertained by DXA, at best combined
with vertebral fracture assessment (VFA) or radiography
examination to detect vertebral fractures, in individuals at risk
of fracture, i.e. at risk of falling [58] or at risk of bone fragility
(history of fracture, low body weight, parental history of hip
fracture, use of glucocorticoids, excessive alcohol consumption,
diseases with bone adverse effects) [74];
 TABM should be considered after a careful assessment of the
beneﬁt/risk ratio in patients at high risk of fracture, i.e. with a
prior fragility fracture or in those with densitometry diagnosed
osteoporosis associated with other risks factors of fractures,
assessed both by fracture prediction scores and risk of falling;
 TABM should not be initiated when the life expectancy is less
than 6–12 months, the minimum time needed for drugs to be
effective in fracture prevention [66].
EUGMS recommends that prospective studies be conducted in
non-selected older people (particularly in those aged over 80 years)
to determine if this strategy is effective, considering that age and
health status may modify compliance to treatments and the
Number-to-treat/number-needed-to-harm (NNH) of TABM [61].
4. Fracture liaison services and screening for spine fragility
As the diagnosis of fragility fracture and the assessment of
beneﬁt/risk ratio of the above measures is complex, EUGMS
recommends that patients aged 65 years or older with vertebral or
non-vertebral fractures should be referred to a fracture liaison
service (FLS) (as proposed by the International osteoporosis
foundation in the capture the fracture initiative) [75], which
should be linked to or have strong input from geriatric medicine
services (combined fall and fracture liaison service). Such an
approach will allow commencement of appropriate interventions
and ensure locally agreed arrangements for follow-up of patients.
This model of care has been shown to be cost-effective [76,77].
EUGMS emphasizes that vertebral compression fractures
are common, and often unrecognized in older people. X-rayexamination should be more systematically performed in older
patients with back pain, signiﬁcant height loss (e.g. 5 cm or more), or
signiﬁcant incident kyphosis. Radiologists should be encouraged to
report on the presence or absence of vertebral deformities as
‘‘fractures’’ when assessing chest radiographs so as to identify
patients who need referral to the combined fall and fracture liaison
services [78], as these are mostly fragility fractures in older people
[53].
5. Conclusion
EUGMS advocates a comprehensive and multidisciplinary
fracture prevention strategy in individuals aged 65 or older
requiring:
 better education for both older people and health care
professionals with regards to general lifestyle and medical
measures to optimize bone health and prevent falls;
 improved knowledge about screening and optimizing manage-
ment of older people with bone fragility or high risk of falling in
primary and community care as well as institutional settings;
 strong collaboration between fracture liaison services, geriatric
medicine departments (combined falls and fracture liaison
services) and primary care.
Policy makers will need to play a major role in developing
community and institutional programs on falls prevention, to
establish falls and fracture liaison services and appropriate
pathways for fracture prevention that include both assessment
and management of fallers and optimising medical management in
those with bone fragility to reduce fracture risk.
The EUGMS believes strongly that the focus for fracture
prevention should not be polarised into either falls prevention
or improving bone health camps. Rather the ideal strategy should
be on optimising bone health, especially in those with bone
fragility, in addition to implementing measures to prevent falls.
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